Company intelligence / Profile preview
RV OPV Pharmaceuticals
Bien Hoa, Dong Nai, Vietnamopv.vn ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
RV OPV Pharmaceuticals is one of the oldest and most reputed pharmaceutical companies in Vietnam. Recently awarded the "Vietnamese Medicine Star" in 2024, recognizing their compliance with stringent quality requirements. The company has upgraded their pill plant to meet EU-GMP manufacturing requirements in 2024 and plans to develop additional projects for injectable drugs and cancer therapies in the next 2-3 years.[4]
- Therapeutic areas
- EndocrinologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculestabletsfilm-coated tabletscapsulesointmentslarge volume parenteralssmall volume parenteralsbetalactam oral and injectionoral powderdisinfectants
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
NatcoHimalaya (Herbal)European manufacturer for insulin repackaging
Beyond the preview
Go deeper on RV OPV Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RV OPV Pharmaceuticals.